BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 34272321)

  • 1. Prevalence of metastases outside the liver and abdominal lymph nodes on
    Wedin M; Janson ET; Wallin G; Sundin A; Daskalakis K
    J Neuroendocrinol; 2024 May; 36(5):e13391. PubMed ID: 38590270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 68Ga-DOTATOC PET/CT in comparison to 111In-Octreotide SPECT/CT in management of neuro-endocrine tumors: A case report.
    Tolomeo A; Lopopolo G; Dimiccoli V; Perioli L; Modoni S; Scilimati A
    Medicine (Baltimore); 2020 Feb; 99(7):e19162. PubMed ID: 32049844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic insulinoma: a systematic review.
    Guerrero-Pérez F; Vilarrasa N; Huánuco LV; Busquets J; Secanella L; Vercher-Conejero JL; Vidal N; Näf Cortés S; Villabona C
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1135-1146. PubMed ID: 37434098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2.
    Olsen IH; Langer SW; Federspiel BH; Oxbøl J; Loft A; Berthelsen AK; Mortensen J; Oturai P; Knigge U; Kjær A
    Am J Nucl Med Mol Imaging; 2016; 6(1):59-72. PubMed ID: 27069766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([
    de Bresser CJM; Petri BJ; Braat AJAT; de Keizer B; van Treijen MJC; Dankbaar JW; Pameijer FA; Kok MGJ; de Ridder M; van Nesselrooij BPM; de Bree R; de Borst GJ; Rijken JA
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative imaging of insulinoma: the end of sampling? A review.
    Christ E; Antwi K; Fani M; Wild D
    Endocr Relat Cancer; 2020 Apr; 27(4):R79-R92. PubMed ID: 31951592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic challenges in a patient with an occult insulinoma:
    Bongetti E; Lee MH; Pattison DA; Hicks RJ; Norris R; Sachithanandan N; MacIsaac RJ
    Clin Case Rep; 2018 Apr; 6(4):719-722. PubMed ID: 29636947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-Negative Neuroendocrine Tumor Identified With 68Ga-DOTATOC PET/CT: A Case of Well-Differentiated Somatostatinoma.
    Moreau A; Chaouat C; Walter T; Dupré A; Kryza D
    Clin Nucl Med; 2024 May; ():. PubMed ID: 38689443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Time-Point 18F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism: A Proof of Concept Study.
    Bani J; Morland D; Hubelé F; Ignat M; Latge A; Bourahla K; Zalzali M; Vix M; Taïeb D; Imperiale A
    Clin Nucl Med; 2021 Dec; 46(12):965-970. PubMed ID: 34524168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review.
    Sidrak MMA; De Feo MS; Corica F; Gorica J; Conte M; Filippi L; Evangelista L; De Vincentis G; Frantellizzi V
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs.
    Grawe F; Rosenberger N; Ingenerf M; Beyer L; Eschbach R; Todica A; Seidensticker R; Schmid-Tannwald C; Cyran CC; Ricke J; Bartenstein P; Auernhammer CJ; Ruebenthaler J; Fabritius MP
    Cancer Imaging; 2023 Apr; 23(1):41. PubMed ID: 37098632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbidopa-assisted
    Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
    Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms.
    Veenstra EB; de Groot DJA; Brouwers AH; Walenkamp AME; Noordzij W
    Clin Nucl Med; 2021 Mar; 46(3):195-200. PubMed ID: 33323729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors.
    Calabrò D; Argalia G; Ambrosini V
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33297381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
    Briganti V; Cuccurullo V; Di Stasio GD; Mansi L
    Curr Radiopharm; 2019; 12(2):156-170. PubMed ID: 30827276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of
    Imperiale A; Boursier C; Sahakian N; Ouvrard E; Chevalier E; Sebag F; Addeo P; Taïeb D
    J Nucl Med; 2022 Mar; 63(3):384-388. PubMed ID: 34272321
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Ouvrard E; Mestier L; Boursier C; Lachachi B; Sahakian N; Chevalier E; Mikail N; Carullo J; Bando-Delaunay A; Walter T; Malouf GG; Addeo P; Poncet G; Sebag F; Lebtahi R; Goichot B; Taïeb D; Imperiale A
    J Nucl Med; 2022 Dec; 63(12):1865-1870. PubMed ID: 35589408
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.